histidine has been researched along with dextromethorphan in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
Allorge, D; Blaney, FE; Bréant, D; Broly, F; Cauffiez, C; Chevalier, D; Chowdry, J; Ellis, SW; Harlow, J; Lhermitte, M; Lo-Guidice, JM; Tucker, GT | 1 |
2 other study(ies) available for histidine and dextromethorphan
Article | Year |
---|---|
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Functional analysis of CYP2D6.31 variant: homology modeling suggests possible disruption of redox partner interaction by Arg440His substitution.
Topics: Amino Acid Substitution; Arginine; Cloning, Molecular; Cytochrome P-450 CYP2D6; Debrisoquin; Dextromethorphan; Gene Frequency; Genetic Variation; Genotype; Histidine; Humans; Kinetics; Microsomes; Oxidation-Reduction; Phenotype; Polymerase Chain Reaction; Recombinant Proteins; Saccharomyces cerevisiae; Substrate Specificity | 2005 |